Hosted on MSN
Novo Nordisk vs Eli Lilly: Which big pharma stock has more upside this year amid earnings season?
・Novo Nordisk cut its 2026 outlook after missing 2025 estimates, while Eli Lilly heads into earnings with a focus on Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results